Nisa Investment Advisors’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Sell
6,980
-74,932
-91% -$2.21M ﹤0.01% 1182
2026
Q1
$2.27M Buy
81,912
+978
+1% +$25.1K 0.01% 574
2025
Q4
$1.76M Buy
80,934
+79,819
+7,159% +$1.57M 0.01% 667
2025
Q3
$16.9K Hold
1,115
﹤0.01% 2072
2025
Q2
$12.6K Sell
1,115
-968
-46% -$10.5K ﹤0.01% 2162
2025
Q1
$21K Buy
2,083
+1,128
+118% +$12.2K ﹤0.01% 1851
2024
Q4
$11.3K Buy
955
+755
+378% +$8.93K ﹤0.01% 2100
2024
Q3
$2.31K Buy
200
+125
+167% +$1.42K ﹤0.01% 2368
2024
Q2
$793 Buy
+75
New +$822 ﹤0.01% 2572

Other funds holding ROIV

Nisa Investment Advisors's ROIV Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Roivant Sciences (ROIV) stake by 91% in Q2 2026, selling an estimated $2.21M and leaving 6,980 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #1182.

Nisa Investment Advisors first reported a position in ROIV in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.27M in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Nisa Investment Advisors held 6,980 shares of Roivant Sciences worth $247K as of Q2 2026.
  • Nisa Investment Advisors sold 74,932 Roivant Sciences shares in Q2 2026, an estimated $2.21M.
  • Roivant Sciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1182 holding.
  • Nisa Investment Advisors first reported a position in Roivant Sciences in Q2 2024 and has held it in 9 quarters since.
  • Nisa Investment Advisors's Roivant Sciences position peaked at $2.27M in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.